Can the U.S. end the HIV epidemic in a decade, as Trump pledged?

President Trump wants to end the HIV epidemic in the U.S. within the 10 years — but experts have warned that's a harder task than his pledge suggests.
A viewer casts a shadow while looking over some 800 AIDS memorial quilt panels on display as part of World AIDS Day at Emory University in Atlanta. Source: David Goldman/AP

President Trump confirmed Tuesday that his administration will attempt to end the HIV epidemic in the United States within the next decade — but experts have warned that’s a harder task than his simple pledge suggests.

Trump’s decision to emphasize the pledge in his State of the Union address, as Politico first reported this weekend, triggered excitement among public health experts who know that with adequate funding for medications and other scientific tools that great inroads could be made in at least reducing the number of infections that occur in the country each year. In 2017, nearly 39,000 Americans contracted HIV.

“Together, we will defeat AIDS in America — and beyond,” Trump told the dignitaries assembled in the House for the State of the Union.

But he offered no details of how his administration hoped to achieve

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
Opinion: Using Social Norms To Drive Positive Changes In Health
Health campaigns can use social norms to focus attention on people doing the right thing, nudging the rest of us to do the same. But when they aren't carefully designed,…
STAT4 min read
Opinion: The Cannabis Boom Could Be Good For Science — And Scientists
For scientists propelled by the thrill of discovery, cannabis — a commonplace yet spectacularly complex plant — offers the chance to set a new course in human understanding and health.
STAT4 min readPolitics
Want To Know How Contentious Drug Pricing Is In Washington? Check The Receipts
PhRMA’s 34 member companies dropped more than $120 million lobbying Congress in 2019 — a sum that helped pay for more than 450 lobbyists.